IMV Inc. ("IMV" or the "Corporation") (NASDAQ:IMV, TSX:IMV), a clinical-stage immuno-oncology corporation, announced today the pricing of its previously-announced underwritten public offering (the
Canadian cannabis retailer Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) reported Thursday that it has finalized the restructuring of its roughly $25.9 million in outstanding debt.
Israel-based alpha-radiation cancer therapy developer Alpha Tau Medical has agreed to merge with a special purpose acquisition company (SPAC) Healthcare Capital…